全球生物活性材料市場的應用、類型、最終用戶、區域範圍和預測

全球生物活性材料市場規模及預測

預計 2024 年全球生物活性材料市場價值將達到 22.2 億美元，2031 年將達到 56.8 億美元，2024 年至 2031 年的複合年成長率為 12.49%。

生物活性材料是與生物系統相互作用並觸發特定反應（例如組織再生和癒合）的化合物。

由於它們能夠與活組織相互作用並改善生物過程，因此已被用於各種應用，包括醫療植入、牙科治療、創傷治療和藥物傳輸系統。

正在進行的研究、開發和技術進步有望擴大再生醫學、個人化醫療保健和創新治療的應用，從而為各種疾病帶來更有效、生物相容的解決方案。

生物活性材料的全球市場動態

影響全球生物活性材料市場的關鍵市場動態包括：

主要市場促進因素：

老化社會與慢性病的流行：老齡人口的成長是生物活性材料發展的主要驅動力。根據世界衛生組織（WHO）的數據，2015年至2050年期間，全球60歲以上人口的比例將增加近一倍，從12%增加到22%。從絕對數量來看，這將使60歲及以上人口的數量從9億增加到20億。這種人口結構的變化與慢性病的發生率上升相吻合。根據世界衛生組織（WHO）的數據，慢性病佔全球整體死亡人數的71%，這推動了醫療應用對生物活性材料的需求。

醫療技術的進步：生物技術和奈米技術的進步正在推動新型生物活性材料的研發，其生物相容性、生物活性和機械強度等性能均有所提升。這些技術突破正在拓展生物活性材料在整形外科、牙科和再生醫學等各個醫療領域的應用。

微創手術日益受到重視：微創手術技術的應用，縮短了恢復時間，降低了併發症風險，推動了對生物活性材料的需求。這些材料對於製造加速癒合和增強組織整合的微創植入和器械至關重要。

新興市場對生物活性材料的認知度和應用度不斷提升：新興經濟體對生物活性材料益處的認知度不斷提升，以及醫療保健投資的不斷增加，正在推動市場擴張。隨著亞太地區和拉丁美洲醫療基礎設施的不斷發展，生物活性材料等創新醫療技術的使用預計將呈指數級成長。

主要挑戰

高昂的開發和生產成本：生物活性材料的開發和生產成本高。根據塔夫茨大學醫學研究與發展中心2023年的研究，開發一種經常使用生物活性物質的新藥的平均成本為26億美元。如此高成本可能會阻礙其廣泛應用，尤其是在貧窮國家。世界衛生組織（WHO）在2021年預測，自付醫療費用每年將使超過1億人陷入極端貧困，凸顯了醫療負擔能力的嚴峻性。

監管障礙和核准流程：生物活性物質受到嚴格的監管審查。根據美國食品藥物管理局(FDA) 的數據，2022 年新醫療設備的核准中位數時間為 290 天，而 2018 年為 243 天，這反映出法律規範日益複雜。歐洲藥品管理局 (EMA) 在 2022 年年度報告中報告稱，其收到了 89 份新藥申請，這表明需要監管審查的新產品數量持續增加。

技術挑戰和性能限制：儘管生物活性材料取得了進展，但仍面臨技術障礙。美國國家標準與技術研究院 (NIST) 報告稱，2024 年，約 30% 的在研生物活性材料未達到長期穩定性標準。他們還指出，提高生物活性材料的機械強度以匹配天然組織仍然是一項重大挑戰，目前的材料只能達到許多應用所需強度的 70-80%。

認知度和接受度有限：儘管人們對生物活性材料的認知度正在不斷提高，但一些醫療專業人士和公眾仍然缺乏理解和接受。這種情況在仍在使用傳統材料和程序的地區尤為明顯。消除疑慮並向相關人員普及生物活性材料的益處和潛力，對於產業發展至關重要。

主要趨勢：

奈米技術整合：奈米技術在生物活性材料中的應用正在改變整個產業。奈米材料具有獨特的特性，例如更大的表面積、更高的生物活性以及在細胞和分子層面相互作用的能力。這種整合有助於創造更有效、更集中的治療方法，尤其是在藥物傳遞系統和組織工程領域。

抗菌生物活性材料：人們對生產具有固有抗菌能力的生物活性材料的興趣日益濃厚。世界衛生組織 (WHO) 預測，如果不採取任何措施，到 2050 年，抗生素抗藥性將導致每年 1,000 萬人死亡。這推動了抗菌生物活性材料的研究。根據 2023 年發表在《材料化學 B 期刊》上的一項研究，2019 年至 2023 年間，抗菌生物活性材料的研究出版物數量增加了 45%。

個人化和精準醫療：生物活性材料市場受到個人化和精準醫療趨勢的影響。客製化生物活性材料的生產旨在滿足個別患者的特定需求，從而提高醫療治療的療效和成功率。這一趨勢在整形外科和牙科領域尤其明顯，患者客製化的植入和植體正變得越來越普遍。

永續性和生物相容性：永續性和生物相容性在生物活性材料的開發中正日益成為重要的考慮因素。研究人員和生產商正在努力開發不僅有效，而且環保且生物相容的材料。這包括使用天然和可生物分解的成分，這些成分副作用更少，更容易被人體吸收和分佈。

目錄

第1章 引言

• 市場定義
• 市場區隔
• 調查方法

第2章執行摘要

• 主要發現
• 市場概況
• 市場亮點

第3章 市場概況

• 市場規模和成長潛力
• 市場趨勢
• 市場促進因素
• 市場限制
• 市場機遇
• 波特五力分析

第4章生物活性材料市場（按類型）

• 生物活性玻璃
• 生物活性陶瓷
• 生物活性複合材料
• 其他

第5章生物活性材料市場（依應用）

• 整形外科、牙科
• 奈米醫學、生物技術
• 其他

第6章生物活性材料市場（按行業）

• 醫療保健和生物醫學
• 化妝品和個人護理
• 食品和農業

第7章區域分析

• 北美洲
• 美國
• 加拿大
• 墨西哥
• 歐洲
• 英國
• 德國
• 法國
• 義大利
• 亞太地區
• 中國
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中東和非洲
• 南非
• 沙烏地阿拉伯
• 阿拉伯聯合大公國

第8章市場動態

• 市場促進因素
• 市場限制
• 市場機遇
• COVID-19 市場影響

第9章 競爭態勢

• 主要企業
• 市佔率分析

第10章：公司簡介

• Zimmer Biomet
• Stryker Corporation
• DePuy Synthes（Johnson & Johnson）
• Medtronic
• GELITA AG
• Baxter International Inc.
• Angstrom Medica
• Nanovis LLC
• Arthrex Inc.
• Berkeley Advanced Biomaterials Inc.
• Biomet Inc.
• CAM Bioceramics BV

第11章 市場展望與機遇

• 新興技術
• 未來市場趨勢
• 投資機會

第12章 附錄

• 簡稱列表
• 來源和參考文獻

Global Bioactive Materials Market Size and Forecast

Global Bioactive Materials Market size was valued at USD 2.22 Billion in 2024 and is projected to reach USD 5.68 Billion by 2031, growing at a CAGR of 12.49% from 2024 to 2031.

Bioactive materials are compounds that interact with biological systems, eliciting a specific response, such as tissue regeneration or healing.

They are employed in a variety of applications, including medical implants, dental care, wound healing, and drug delivery systems, because of their capacity to interact with biological tissues and improve biological processes.

The future of bioactive materials is vast, with ongoing research and technological advancements poised to expand their use in regenerative medicine, personalized healthcare, and innovative medical treatments, resulting in the development of more effective and biocompatible solutions for a wide range of conditions.

Global Bioactive Materials Market Dynamics

The key market dynamics that are shaping the global bioactive materials market include:

Key Market Drivers:

Aging Population and Increasing Prevalence of Chronic Diseases: The rising senior population is a major driver of bioactive materials. According to the World Health Organization (WHO), the proportion of the global population over the age of 60 will nearly double between 2015 and 2050, from 12% to 22%. In absolute terms, this represents a rise from 900 million to 2 billion people over the age of sixty. This demographic transition coincides with a rise in chronic diseases. According to the World Health Organization, chronic diseases account for 71% of all deaths worldwide, increasing the demand for bioactive materials in medical applications.

Advancements in Medical Technology: Rising advances in biotechnology and nanotechnology are resulting in the creation of new bioactive materials with improved features such as biocompatibility, bioactivity, and mechanical strength. These technical breakthroughs broaden the use of bioactive materials in a variety of medical sectors, including orthopedics, dentistry, and regenerative medicine.

Increasing Emphasis on Minimally Invasive Procedures: The transition to less invasive surgical techniques, which have shorter recovery times and decreased risk of problems, increases demand for bioactive materials. These materials are essential for creating minimally invasive implants and devices that enable faster healing and greater integration with biological tissues.

Rising Awareness and Adoption of Bioactive Materials in Emerging Markets: Growing awareness of the benefits of bioactive materials, as well as increased healthcare investment in emerging nations, are driving market expansion. As healthcare infrastructure develops throughout Asia-Pacific and Latin America, the use of innovative medical technology, such as bioactive materials, is predicted to increase dramatically.

Key Challenges:

High Costs of Development and Production: Bioactive materials have high development and production costs. According to a 2023 research by the Tufts Center for the Study of medicine Development, the average cost of developing a new medicine, which frequently incorporates bioactive materials, is USD 2.6 Billion. This high cost may impede wider use, especially in poor countries. The World Health Organization projected in 2021 that out-of-pocket health spending pushes over 100 million people into extreme poverty each year, highlighting the difficulty of healthcare affordability.

Regulatory Hurdles and Approval Processes: Bioactive materials are subject to strict regulatory monitoring. According to the United States Food and Drug Administration (FDA), the median time to clearance for new medical devices in fiscal year 2022 was 290 days. For instance, in 2018, the figure was 243 days, reflecting an increasingly complicated regulatory framework. The European medications Agency (EMA) reported in its 2022 annual report that it received 89 applications for new medications, illustrating the ongoing influx of new goods that require regulatory review.

Technical Challenges and Performance Limitations: Despite developments, bioactive materials continue to encounter technical hurdles. The National Institute of Standards and Technology (NIST) reported in 2024 that around 30% of bioactive materials in development do not meet long-term stability standards. The paper also stated that enhancing the mechanical strength of bioactive materials to match natural tissues is still a big problem, with current materials only achieving 70-80% of the needed strength in many applications.

Limited Awareness and Acceptance: While there is increasing awareness of bioactive materials, some healthcare professionals and people continue to lack understanding and acceptability. This is especially true in locations where traditional materials and procedures are still used. Overcoming skepticism and educating stakeholders about the benefits and possibilities of bioactive materials is critical to industry growth.

Key Trends:

Integration of Nanotechnology: The introduction of nanotechnology into bioactive materials is transforming the industry. Nanomaterials have distinct features such as expanded surface area, greater bioactivity, and the capacity to interact at both the cellular and molecular levels. This integration is helping to produce more effective and focused medical treatments, particularly in drug delivery systems and tissue engineering.

Antimicrobial Bioactive Materials: There is an increasing interest in producing bioactive materials with inherent antibacterial capabilities. The World Health Organization forecasts that if no action is taken, antibiotic resistance will kill 10 million people each year by 2050. This has prompted studies into antibacterial bioactive materials. A study published in the Journal of Materials Chemistry B in 2023 found that research publications on antibacterial bioactive materials increased by 45% between 2019 and 2023.

Personalized and Precise Medicine: The bioactive materials market is being influenced by the trend towards personalized and precision medicine. Customized bioactive materials are being produced to meet the specific demands of individual patients, hence increasing the effectiveness and outcomes of medical therapies. This trend is especially noticeable in orthopedics and dental care, where patient-specific implants and grafts are becoming increasingly common.

Sustainable and Biocompatible: Sustainability and biocompatibility are increasingly important considerations in the creation of bioactive materials. Researchers and producers are working to develop materials that are not only effective, but also eco-friendly and biocompatible. This includes the use of natural and biodegradable ingredients that cause fewer adverse effects and are securely integrated or absorbed by the body.

Global Bioactive Materials Market Regional Analysis

Here is a more detailed regional analysis of the global bioactive materials market:

Asia Pacific:

The Asia Pacific region is experiencing the fastest growth in the bioactive materials market, owing to a combination of positive factors. A growing population, notably in China and India, is driving a strong need for innovative medical solutions.

This demand is exacerbated by increase in healthcare spending in these countries, where both the government and private sector engage in upgrading healthcare infrastructure and accessibility. Another important market driver is the rising frequency of chronic disorders such as orthopedic and cardiovascular diseases.

Bioactive materials provide novel therapy options for various disorders, enabling faster healing, increased functionality, and potentially minimizing the need for additional procedures. Supportive government measures are critical to boosting industry growth. These programs focus on development.

North America:

North America dominates the global bioactive materials market, with the United States at the top. This supremacy is the result of a combination of favorable factors. A strong healthcare infrastructure, including well-equipped hospitals, trained medical workers, and cutting-edge medical technologies, creates an ideal environment for the adoption of innovative bioactive materials.

Furthermore, significant investments in R&D by both public and commercial enterprises drive ongoing innovation in this field. Furthermore, a supportive regulatory framework that prioritizes safety and efficacy promotes market expansion.

Aside from its robust infrastructure, North America's demographic trends help it lead the bioactive materials market. A big and expanding older population, combined with an increasing frequency of chronic disorders including orthopedic ailments and cardiovascular diseases, considerably strengthens the There is a high need for sophisticated medical gadgets and implants made using bioactive materials. This demand is fueled by rising healthcare spending, as consumers and insurance companies grow more open to innovative treatment choices that enhance patient outcomes while potentially lowering long-term healthcare expenditures.

Finally, the presence of a large number of significant market players in North America reinforces the region's supremacy. These prominent companies not only invest extensively in R&D, but also form strategic alliances and partnerships to speed up the development and commercialization of next-generation bioactive materials. This fierce rivalry creates a dynamic and innovative atmosphere, moving the market ahead.

Global Bioactive Materials Market: Segmentation Analysis

The Global Bioactive Materials Market is segmented on the basis of By Application, By Type, By End-User, and By Geography.

Global Bioactive Materials Market, By Application

Orthopedics

Dental Care

Nanomedicines & Biotechnology

Based on Application, the Global Bioactive Materials Market is segmented into Orthopedics, Dental Care, and Nanomedicines & Biotechnology. The orthopedics segment dominates due to the widespread usage of bioactive materials in bone healing, joint replacement, and spinal implants. The growing prevalence of orthopedic ailments, combined with an aging population, is driving demand in this category. Nanomedicines & Biotechnology is the fastest-growing segment, spurred by advances in nanotechnology and its use in targeted medication delivery and regenerative medicine. The increased emphasis on customized medicine and innovative therapeutic solutions is driving the segment's rapid growth.

Global Bioactive Materials Market, By Type

Bioactive Glass

Bioactive Ceramics

Bioactive Composites

Based on Type, the Global Bioactive Materials Market is segmented into Bioactive Glass, Bioactive Ceramics, and Bioactive Composites. The bioactive glass segment dominates due to its widespread use in bone regeneration, dental care, and tissue engineering. The segment's exceptional features, including as biocompatibility and capacity to bind with bone, make it a popular choice for medical treatments. Bioactive Composites is the fastest-growing segment, thanks to their many uses and the growing need for sophisticated, multifunctional materials in both medical and dentistry fields. Their capacity to combine various bioactive components to improve performance drives their rapid growth.

Global Bioactive Materials Market, By End-User

Healthcare & Biomedical

Cosmetics & Personal Care

Food & Agriculture

Based on End-User, the Global Bioactive Materials Market is segmented into Healthcare & Biomedical, Cosmetics & Personal Care, and Food & Agriculture. The healthcare & biomedical segment is dominating, owing to the widespread usage of bioactive materials in medical implants, tissue engineering, and drug delivery devices. The ongoing improvements in medical technology, as well as the growing need for novel healthcare solutions, maintain this segment's leadership position. Cosmetics & personal care is the fastest-growing segment, driven by rising customer demand for products containing bioactive compounds that provide better skin care benefits and anti-aging qualities. Growing knowledge of the efficacy and safety of bioactive compounds in cosmetics is driving the segment's rapid growth.

Global Bioactive Materials Market, By Geography

North America

Europe

Asia Pacific

Rest of the World

Based on the Geography, the Global Bioactive Materials Market are classified into North America, Europe, Asia Pacific, and Rest of the World. North America is the dominating region, owing to superior healthcare infrastructure, significant R&D investments, and the presence of key industry players. This region benefits from major technological breakthroughs and a strong emphasis on innovative medical solutions, which contribute to its dominant position. Asia Pacific is the fastest-growing area, driven by expanding demand for innovative medical treatments, rising healthcare costs, and rapid industrialization. The increased awareness of the benefits of bioactive materials, as well as the expansion of medical tourism, contribute to the market's quick rise in this region.

Key Players

The "Global Bioactive Materials Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Zimmer Biomet, Stryker Corporation, DePuy Synthes (Johnson & Johnson), Medtronic, GELITA AG, Baxter International Inc., Angstrom Medica.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Global Bioactive Materials Market: Recent Developments
• In January 2024, Italian biomaterials startup Mogu, which will shortly be rebranded Sqim, has raised €11 million (USD 12 Million) in Series A funding from French fashion giant Kering to grow its mycelium-based technology. Mogu plans to utilize the financing to establish a prototype production plant, grow its personnel, and extend its research and development of mycelium-based goods for areas such as fashion and automotive.
• In January 2024, Xenco Medical showcased their TrabeculeX Continuum(TM), a convergent technology that connects digital health and biomaterials, at the 2024 Consumer Electronics Show in Las Vegas, Nevada. The TrabeculeX Continuum, which includes the FDA-cleared TrabeculeX Bioactive Matrix(TM) and TrabeculeX Recovery App(TM), is the first technology-enabled bridge between orthobiologics and digital health. It unifies a patient's biomaterial implantation and postoperative experience. The TrabeculeX Continuum enables surgeons who have implanted Xenco Medical's FDA-cleared TrabeculeX Bioactive Matrix to enroll patients in the TrabeculeX Recovery App and engage in both Remote Therapeutic Monitoring and asynchronous video and text messaging. It is an unprecedented intersection of regenerative medicine and digital health.
• In July 2023, DSM Biomedical has introduced a unique bioactive ceramic material for dental and orthopedic implants. This material is designed to improve Osseo integration and promote quicker healing, addressing the growing demand for effective and dependable implant materials.
• In September 2023, Medtronic has revealed a breakthrough in bioactive coatings for medical implants, with a focus on increasing the biocompatibility and performance of cardiovascular and orthopedic implants. This development intends to lower the likelihood of implant rejection while also improving implant integration with neighboring tissues.
• In October 2023, Schott AG announced the creation of a new generation of bioactive glass materials intended for dentistry and orthopedic applications. This novel bioglass has higher bioactivity and mechanical strength, making it ideal for a wider range of medical applications.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Bioactive Materials Market, By Type

• Bioactive Glass
• Bioactive Ceramics
• Bioactive Composites
• Others

5. Bioactive Materials Market, By Application

• Orthopedics, Dental Care
• Nanomedicines and Biotechnology
• Others

6. Bioactive Materials Market, By Industry

• Healthcare & Biomedical
• Cosmetics & Personal Care
• Food & Agriculture

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Zimmer Biomet
• Stryker Corporation
• DePuy Synthes (Johnson & Johnson)
• Medtronic
• GELITA AG
• Baxter International Inc.
• Angstrom Medica
• Nanovis LLC
• Arthrex Inc.
• Berkeley Advanced Biomaterials Inc.
• Biomet Inc.
• CAM Bioceramics B.V.

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References